HPV vaccination schedule in the adolescent's girls is?

Appeared in: NORCET 3 - 2022 (Shift-2)

Explanation

For adolescents initiating the HPV vaccine series before their 15th birthday, the standard recommendation is a 2-dose schedule.
This is based on evidence that younger adolescents (ages 9-14) produce a stronger, more robust immune response to the vaccine than older adolescents and young adults.
The recommended interval for the 2-dose series is a second dose administered 6 to 12 months after the first dose (0, 6-12 months).
This schedule provides protection comparable to the 3-dose series given to older individuals.

Option A: This describes a 3-dose schedule (0, 2, 6 months), which is not the standard for healthy adolescents under 15 years old.
Option B: This describes a 3-dose schedule (0, 1, 6 months), which is incorrect for the specified age group of under 15 years.
Option C: This is a 3-dose schedule with an incorrect interval (0, 6, 12 months). A 3-dose series is not standard for this age group, and this specific interval is not a recommended schedule.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain HPV vaccination schedule in adolescents as background academic context rather than a clinical decision trigger.
Nurses play a crucial role in educating parents and adolescents about the importance of the HPV vaccine and adhering to the correct schedule for maximum efficacy.
It is a critical nursing responsibility to verify the patient's age before administering the vaccine to ensure the correct dosing schedule (2-dose vs. 3-dose) is initiated.
Post-vaccination, nurses should observe the adolescent for about 15 minutes, as syncope (fainting) is more common in this age group after any vaccination.

How to Approach the Question

First, identify the key components of the question: 'HPV vaccination', 'schedule', and the specific population 'adolescent girls <15 years'.
Recall the standard immunization guidelines for HPV. The key differentiator is the age of initiation: before or after the 15th birthday.
Remember that for the younger group (<15 years), the immune response is more robust, allowing for a 2-dose schedule.
Evaluate each option. Eliminate the 3-dose schedules (A, B, C) as they are intended for older or immunocompromised individuals.
Select the option that describes a 2-dose schedule, recognizing that the standard is a 0 and 6-12 month interval.

Concept Tested & Keywords

QDGRtk1KyJq4zQkNz8QPmU

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 p. 2063-2065

E6 Gynecology Williams p. 211-253

Practise the full NORCET 3 - 2022 (Shift-2)

Attempt every question from this paper in a timed mock, then review the full solution for each one.